Skip to main content

Arthrex Knee Implant Suit Moves Forward in Pa. Federal Court

Arthrex Knee Implant Suit Moves Forward in Pa. Federal Court

Arthrex Knee Implant Suit Moves Forward in Pa. Federal Court

Introduction

In an order issued on February 27, Judge A. Richard Caputo of the U.S. District Court for the Middle District of Pennsylvania refused to toss a lawsuit involving complaints against Arthrex Inc.'s iBalance knee implant, ruling that the claims filed were timely because the limitations period did not begin until the plaintiff's second knee implant failed.

The lawsuit involved allegations by a couple that the iBalance knee devices implanted in the woman's knee twice were defective. The Pennsylvania court found that a question of fact existed whether the negligence claims were preempted by federal law. Similar complaints regarding knee implant failure have been filed against other manufacturers like Zimmer  Inc., Stryker Corporation, and DePuy Orthopedics. Recently, plaintiffs involved in the Zimmer NexGen knee implant litigation agreed to be part of a global settlement program to resolve most of the lawsuits pending in the state and federal courts.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!